¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"effect modification"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
allotropic modification
µ¿¼Òüº¯Çü
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯Çü, º¯È, º¯°æ, ¼ö½Ä, ¼öÁ¤
phenotypic modification
Ç¥ÇöÇüº¯È
antagonistic effect
´ëÇ×È¿°ú
anticoagulant effect
Ç×ÀÀ°íÈ¿°ú
antioxidant effect
Ç×»êÈÈ¿°ú
antitussive effect
Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
additive effect
ºÎ°¡È¿°ú
adverse effect
À¯ÇØÈ¿°ú
beam hardening effect
ºö°æÈÈ¿°ú
back-pressure effect
ÈĹæ¾Ð·ÂÈ¿°ú
biologic effect
»ý¹°ÇÐÀûÈ¿°ú
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
14
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
modification
º¯È, ¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
effect
È¿°ú, ÀÛ¿ë
adverse effect
(¢¡ adverse event) À¯ÇذæÇè
anticoagulant effect
Ç×ÀÀ°íÈ¿°ú
antioxidant effect
Ç×»êÈÈ¿°ú
inhibitory effect
¾ïÁ¦È¿°ú
palliative effect
¿ÏÈÈ¿°ú, °æ°¨È¿°ú
prolonged effect
Áö¼ÓÈ¿°ú
radiation effect
¹æ»ç¼±È¿°ú
reversing effect
¿ªÀüÈ¿°ú
shielding effect
Â÷ÆóÈ¿°ú, °¡¸²È¿°ú
stochastic effect
È®·ü·ÐÀûÈ¿°ú
synergistic effect
»ó½ÂÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯È, ¼ö½Ä
phenotypic modification
Ç¥ÇöÇüº¯È
acute normal tissue effect
Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
additive effect
ºÎ°¡È¿°ú, »ó°¡È¿°ú
adverse effect
¿ªÈ¿°ú, À¯ÇØÈ¿°ú
antagonistic effect
¸Â¹öÆÀÈ¿°ú, ´ëÇ×È¿°ú
anticoagulant effect
Ç×ÀÀ°íÈ¿°ú
antioxidant effect
Ç×»êÈÈ¿°ú
antitoxemic effect
Ç×µ¶Ç÷ÁõÈ¿°ú
antitussive effect
Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
back-pressure effect
ÈĹæ¾Ð·ÂÈ¿°ú
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
Bernouilli effect
º£¸£´©ÀÌ È¿°ú
Bohr effect
º¸¾Æ È¿°ú(üùÍý)
CPE=£¾cytopathogenic effect
¼¼Æ÷º´º¯È¿°ú.
CPE=£¾cytopathogenic effect
¼¼Æ÷º´º¯È¿°ú.
Cytopath(ogen)ic effect, CPE
¼¼Æ÷º´º¯È¿°ú
Donnan effect
µ·³È¿°ú
Doppler effect
µµÇ÷¯ È¿°ú
Fahraeus-Lindqvist effect
ÆÄ·¹¿ì½º-¸°Äûºñ½ºÆ® È¿°ú(üùÍý)
Fenn effect
Ææ È¿°ú(üùÍý)
Gibbs effect
±é½º È¿°ú
HIV effect
HIV È¿°ú<ÀÛ¿ë>
Haldane effect
ÇÒµ§È¿°ú
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
behavior modification technique
Çൿ(ÇàÅÂ)¼öÁ¤±â¹ý
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification of karyotype
ÇÙÇüº¯ÀÌ
modification, behavioral
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
additive effect
»ó°¡È¿°ú (ßÓÊ¥üùÍý)
additive effect
ºÎ°¡È¿°ú
adverse effect
¿ªÈ¿°ú, À¯ÇØÈ¿°ú
adverse effect
¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
air barrier effect
°ø±â¸·È¿°ú(ÍöѨدüùÍý).
air gap effect
°ø±â °£°Ý È¿°ú
allogeneic effect
µ¿Á¾ÀÌÇüÈ¿°ú
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½